Erythema multiforme: As a complication of allergen-specific immunotherapy

Allergologia et Immunopathologia

Volumn 29, Issue 6, 2001, Pages 276-278

  Karakaya, G ^a   Sahin S ^a   Fuat Kalyoncu, A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Erythema multiforme; Specific immunotherapy

Indexed keywords

ALLERGEN; FUNGUS ANTIGEN; GLYCOPROTEIN; HOUSE DUST ALLERGEN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADULT; ANIMAL; ARTICLE; CASE REPORT; DESENSITIZATION; ERYTHEMA MULTIFORME; FEMALE; FUNGUS; HUMAN; IMMUNOLOGY; MITE; PERENNIAL RHINITIS;

ADULT; ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ANTIGENS, FUNGAL; DESENSITIZATION, IMMUNOLOGIC; ERYTHEMA MULTIFORME; FEMALE; FUNGI; GLYCOPROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MITES; PREDNISOLONE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0035522824     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0546(01)79070-2     Document Type: Article

References (3)

1. Rotne H. Very late reactions to allergen-specific immunotherapy caused by physical exercise. Allergy 2000; 55: 194.
2. Weiss SJ. Localized fibrosis associated with immunotherapy? J Allergy Clin Immunol 1991; 88: 423-4.
3. Fritsch PO, Ruiz-Maldonado R. Erythema multiforme. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds. Dermatology in General Medicine. New York: McGraw-Hill, 1999; 1: 636-44.